Cancer Genetics Company Profile (NASDAQ:CGIX)

About Cancer Genetics

Cancer Genetics, Inc. is engaged in the field of personalized medicine, enabling precision medicine in the field of oncology through its diagnostic products and services, and molecular markers. The Company develops, commercializes and provides molecular- and biomarker-based tests and services that enable physicians to personalize the clinical management of each individual patient by providing genomic information to diagnose, monitor and inform cancer treatment, and enable biopharmaceutical companies engaged in oncology trials to select candidate populations and manage adverse drug reactions by providing information regarding genomic factors influencing subject responses to therapeutics. It has a range of disease-focused oncology testing portfolio. Its molecular- and biomarker-based diagnostic services are provided for three sectors: cancer centers and hospitals, biotechnology and biopharmaceutical companies, and the research community.

Industry, Sector and Symbol:

• Sector: Medical
• Industry: Medical Laboratories & Research
• Sub-Industry: N/A
• Exchange: NASDAQ
• Symbol: CGIX
• CUSIP:

Key Metrics:

• Previous Close: $1.79
• 50 Day Moving Average: $2.05
• 200 Day Moving Average: $2.25
• 52-Week Range: $1.72 - $8.51
• Trailing P/E Ratio: N/A
• Foreward P/E Ratio: -2.75
• P/E Growth: -0.04
• Market Cap: $28.85M
• Outstanding Shares: 16,120,000
• Beta: 1.08

Profitability:

• Net Margins: -89.60%
• Return on Equity: -72.29%
• Return on Assets: -47.11%

Debt:

• Debt-to-Equity Ratio: 0.13%
• Current Ratio: 2.42%
• Quick Ratio: 2.42%

Additional Links:

• Visit Cancer Genetics' Official Website
• View CGIX on Google Finance
• View CGIX on Yahoo Finance
• View CGIX's Company Profile on Reuters
• Search for Cancer Genetics Inc. on Google

Companies Related to Cancer Genetics:

• AVEO Pharmaceuticals (NASDAQ:AVEO)
• BioLineRx (NASDAQ:BLRX)
• Vericel Corp. (NASDAQ:VCEL)
• Sunesis Pharmaceuticals (NASDAQ:SNSS)
• Intec Pharma Ltd (NASDAQ:NTEC)
• KemPharm (NASDAQ:KMPH)
• MEI Pharma (NASDAQ:MEIP)
• Juniper Pharmaceuticals (NASDAQ:JNP)
• Avinger (NASDAQ:AVGR)
• Eleven Biotherapeutics (NASDAQ:EBIO)

Earnings

Earnings History for Cancer Genetics (NASDAQ:CGIX)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call	Details
11/8/2016
8/10/2016	Q216	($0.33)	($0.28)	$6.50 million	$7.00 million	View	N/A
5/10/2016	Q1	($0.43)	($0.39)	$6.95 million	$6.10 million	View	Listen
3/10/2016	Q415	($0.46)	($0.48)	$7.00 million	$5.50 million	View	Listen
11/10/2015	Q315	($0.49)	($0.56)	$5.13 million	$4.00 million	View	Listen
8/11/2015	Q215	($0.50)	($0.51)	$4.67 million	$4.20 million	View	Listen
5/12/2015	Q115	($0.54)	($0.44)	$3.91 million	$4.40 million	View	Listen
3/12/2015	Q414	($0.50)	($0.49)	$3.70 million	$4.00 million	View	N/A
11/10/2014		($0.51)	($0.41)			View	N/A
8/14/2014	Q214	($0.37)	($0.50)	$2.13 million	$3.20 million	View	N/A
5/15/2014	Q114	($0.29)	($0.27)	$2.17 million	$1.40 million	View	N/A
3/26/2014	Q4 13	($0.36)	($0.37)	$1.95 million	$1.90 million	View	N/A
11/13/2013	Q313	($0.71)	($0.61)	$1.60 million	$1.70 million	View	N/A

(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Cancer Genetics (NASDAQ:CGIX)

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2016	2	($0.38)	($0.28)	($0.33)
Q2 2016	1	($0.33)	($0.33)	($0.33)
Q3 2016	1	($0.29)	($0.29)	($0.29)
Q4 2016	1	($0.24)	($0.24)	($0.24)

(Data provided by Zacks Investment Research)

Dividends

Dividend History for Cancer Genetics (NASDAQ:CGIX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Cancer Genetics (NASDAQ:CGIX)

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Details
8/16/2016	John Pappajohn	Director	Buy	45,000	$2.29	$103,050.00
8/15/2016	John Pappajohn	Director	Buy	147,500	$2.16	$318,600.00
3/17/2016	John Pappajohn	Director	Buy	50,000	$2.64	$132,000.00
3/17/2016	Panna Sharma	CEO	Buy	1,500	$2.59	$3,885.00
3/16/2016	John Pappajohn	Director	Buy	100,000	$2.53	$253,000.00
3/15/2016	Panna Sharma	CEO	Buy	1,000	$2.56	$2,560.00
8/27/2015	John Pappajohn	Director	Buy	5,000	$9.61	$48,050.00
6/25/2015	Raju S.K. Chaganti	Director	Sell	5,296	$12.00	$63,552.00
6/12/2015	Raju S.K. Chaganti	Director	Sell	7,000	$12.01	$84,070.00
6/11/2015	Raju S.K. Chaganti	Director	Sell	46,454	$12.03	$558,841.62
6/8/2015	Raju S.K. Chaganti	Director	Sell	24,583	$12.03	$295,733.49
5/14/2015	John Pappajohn	Director	Buy	5,000	$10.74	$53,700.00
3/17/2015	John Pappajohn	Director	Buy	50,000	$7.36	$368,000.00
3/16/2015	Edward J Sitar	CFO	Buy	1,000	$6.99	$6,990.00
12/16/2014	John Pappajohn	Director	Buy	5,589	$6.20	$34,651.80
12/15/2014	John Pappajohn	Director	Buy	3,634	$6.14	$22,312.76
12/11/2014	John Pappajohn	Director	Buy	27,087	$6.03	$163,334.61
12/10/2014	John Pappajohn	Director	Buy	5,773	$5.96	$34,407.08
12/9/2014	John Pappajohn	Director	Buy	39,686	$5.35	$212,320.10
5/21/2014	Edward Sitar	CFO	Buy	1,000	$10.67	$10,670.00
5/21/2014	John Pappajohn	Director	Buy	50,000	$10.31	$515,500.00

(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Cancer Genetics (NASDAQ:CGIX)

Date	Headline
	Interested Penny Stock Investors Keen on Shares of Cancer Genetics, Inc. (NASDAQ:CGIX) - Duncan Research (NASDAQ:CGIX) www.duncanindependent.com - September 28 at 4:03 PM
	Cancer Genetics : Announces $5.5 Million Registered Direct Offering (NASDAQ:CGIX) www.4-traders.com - September 28 at 9:01 AM
	Cancer Genetics : to Present at Two Upcoming Investor Conferences During September (NASDAQ:CGIX) www.4-traders.com - September 27 at 4:09 PM
	Cancer Genetics, Inc. Announces a Global Partnership with BARC Global Central Laboratory to Offer Comprehensive Clinical Trial and Companion Diagnostic Solutions for the Oncology Industry (NASDAQ:CGIX) www.publicnow.com - September 27 at 4:09 PM
	Stock Noted Gapping Up Pre-Market: Cancer Genetics, Inc. (NASDAQ:CGIX) - Post News (NASDAQ:CGIX) www.kentuckypostnews.com - September 27 at 8:46 AM
	Cancer Genetics, Inc. (NASDAQ:CGIX) To Hit Price Target Of $5.75? - Investor Newswire (NASDAQ:CGIX) www.investornewswire.com - September 27 at 8:46 AM
	Rodman & Renshaw Prescribe A $6 Price Target For Cancer Genetics (NASDAQ:CGIX) www.benzinga.com - September 26 at 4:25 PM
	Cancer Genetics (CGIX), ApoCell Enter Strategic Partnership for Circulating Tumor Cells (NASDAQ:CGIX) www.streetinsider.com - September 26 at 8:57 AM
	Cancer Genetics, Inc. and ApoCell Announce Partnership Focused on Transforming Cancer Profiling & Therapy Selection Leveraging Proprietary, High-Performance, Liquid Biopsy Platform for Rare Cell Capture and Detection (NASDAQ:CGIX) finance.yahoo.com - September 26 at 8:57 AM
	Keen Investors Find News on Cancer Genetics, Inc. (NASDAQ:CGIX) - Duncan Research (NASDAQ:CGIX) www.duncanindependent.com - September 24 at 8:25 AM
	Under the Microscope, Zeroing in at Cancer Genetics, Inc. (NASDAQ:CGIX) - Duncan Research (NASDAQ:CGIX) www.duncanindependent.com - September 22 at 4:22 PM
	Cancer Genetics Inc's (NASDAQ:CGIX) Partnership With BARC Will Enhance Effective Delivery Of Solutions In The ... - Scibility Media (NASDAQ:CGIX) scibilitymedia.com - September 22 at 4:22 PM
	Cancer Genetics, Inc. Announces a Global Partnership with [..] (NASDAQ:CGIX) www.pr-inside.com - September 21 at 4:49 PM
	Penny Stock Investors Take an Interest in Cancer Genetics, Inc. (NASDAQ:CGIX) - Duncan Research (NASDAQ:CGIX) www.duncanindependent.com - September 21 at 8:13 AM
	Cancer Genetics, Inc. Announces a Global Partnership with BARC Global Central Laboratory to Offer Comprehensive ... - Yahoo Finance (NASDAQ:CGIX) finance.yahoo.com - September 21 at 8:13 AM
	Cancer Genetics, Inc. to Present at Two Upcoming Investor Conferences During September - GlobeNewswire (press release) (NASDAQ:CGIX) www.globenewswire.com - September 21 at 8:13 AM
	Cancer Genetics, Inc. to Present at Two Upcoming Investor Conferences During September (NASDAQ:CGIX) finance.yahoo.com - September 21 at 8:13 AM
	CANCER GENETICS, INC Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:CGIX) biz.yahoo.com - September 17 at 8:56 AM
	Cancer Genetics (CGIX) Enters 2.75M Share Registered Direct Offering (NASDAQ:CGIX) www.streetinsider.com - September 10 at 3:59 PM
	Cancer Genetics : to Present at the Rodman & Renshaw 18th Annual Global Investment Conference (NASDAQ:CGIX) www.4-traders.com - September 9 at 4:03 PM
	Cancer Genetics, Inc. to Present at the Rodman & Renshaw 18th Annual Global Investment Conference (NASDAQ:CGIX) m.nasdaq.com - September 9 at 4:03 PM
	Cancer Genetics (CGIX) Enters 2.75M Share Registered Direct Offering - StreetInsider.com (NASDAQ:CGIX) www.streetinsider.com - September 9 at 9:00 AM
	Cancer Genetics, Inc. to Present at the Rodman & Renshaw 18th Annual Global Investment Conference - GlobeNewswire (press release) (NASDAQ:CGIX) globenewswire.com - September 9 at 9:00 AM
	Cancer Genetics Announces $5.5 Million Registered Direct Offering (NASDAQ:CGIX) finance.yahoo.com - September 9 at 9:00 AM
	CANCER GENETICS, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Secu (NASDAQ:CGIX) biz.yahoo.com - September 9 at 9:00 AM
	ETF’s with exposure to Cancer Genetics, Inc. : August 29, 2016 (NASDAQ:CGIX) www.capitalcube.com - August 29 at 3:34 PM
	CANCER GENETICS, INC Financials (NASDAQ:CGIX) finance.yahoo.com - August 19 at 4:50 PM
	Cancer Genetics, Inc.'s (CGIX): Really worthy Stock of Yesterday - Hot Stocks Point (NASDAQ:CGIX) www.hotstockspoint.com - August 18 at 4:12 PM
	Recent Insider Activity: Cancer Genetics (CGIX) - The Voice Registrar (NASDAQ:CGIX) voiceregistrar.com - August 18 at 4:12 PM
	Cancer Genetics' (CGIX) Focus::Myeloid NGS-Based Panel Receives Approval in New York State (NASDAQ:CGIX) www.streetinsider.com - August 18 at 11:41 AM
	Stock Gapping Up Pre-Market: Cancer Genetics, Inc. (NASDAQ:CGIX) - Post News (NASDAQ:CGIX) www.kentuckypostnews.com - August 17 at 4:19 PM
	Cancer Genetics, Inc. Strengthens Position as a Leader in Myeloid Cancer Diagnosis and Management Receiving New York State Approval for… (NASDAQ:CGIX) forextv.com - August 17 at 11:46 AM
	Cancer Genetics, Inc. Strengthens Position as a Leader in Myeloid Cancer Diagnosis and Management Receiving New York State Approval for Focus::Myeloid™, a Targeted NGS Panel for Improved Diagnosis, Risk Stratification, and Therapy Selection (NASDAQ:CGIX) finance.yahoo.com - August 17 at 11:46 AM
	7:31 am Cancer Genetics receives NY State approval for its Focus::Myeloid NGS-based panel for myeloid malignancies including acute myeloid leukemia, myelodysplastic syndrome, and myeloproliferative neoplasms (NASDAQ:CGIX) finance.yahoo.com - August 17 at 11:46 AM
	ETF’s with exposure to Cancer Genetics, Inc. : August 15, 2016 (NASDAQ:CGIX) www.capitalcube.com - August 15 at 11:26 AM
	Cancer Genetics, Inc. :CGIX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 (NASDAQ:CGIX) www.capitalcube.com - August 12 at 12:16 PM
	Cancer Genetics Inc. (NASDAQ: CGIX) reports quarterly earnings - BNB Daily (blog) (NASDAQ:CGIX) www.baseball-news-blog.com - August 11 at 11:58 AM
	Cancer Genetics reports 2Q loss - Yahoo Finance (NASDAQ:CGIX) finance.yahoo.com - August 10 at 4:13 PM
	Cancer Genetics, Inc. Reports Second Quarter 2016 Financial Results and Provides Company Updates (NASDAQ:CGIX) www.nasdaq.com - August 9 at 9:58 PM
	Cancer Genetics reports 2Q loss (NASDAQ:CGIX) sg.finance.yahoo.com - August 9 at 9:58 PM
	CANCER GENETICS, INC Files SEC form 10-Q, Quarterly Report (NASDAQ:CGIX) biz.yahoo.com - August 9 at 4:28 PM
	Cancer Genetics to Report Second Quarter Earnings on Wednesday, August 10 - GlobeNewswire (press release) (NASDAQ:CGIX) globenewswire.com - August 2 at 4:16 PM
	New Broker Ratings For Cancer Genetics, Inc. (CGIX) - FTSE News (NASDAQ:CGIX) www.ftsenews.co.uk - August 2 at 4:16 PM
	Cancer Genetics to Report Second Quarter Earnings on Wednesday, August 10 (NASDAQ:CGIX) finance.yahoo.com - August 2 at 8:58 AM
	Shares Stumbling of Late: Cancer Genetics, Inc. (NASDAQ:CGIX) - TGP (NASDAQ:CGIX) telanaganapress.com - July 23 at 4:08 PM
	CANCER GENETICS, INC Files SEC form 8-K, Shareholder Director Nominations (NASDAQ:CGIX) biz.yahoo.com - July 22 at 4:05 PM
	Insiders Increasing Positions in: Cancer Genetics, Inc. (NASDAQ:CGIX) - Press Telegraph (NASDAQ:CGIX) presstelegraph.com - July 22 at 12:20 PM
	Cancer Genetics Inc (NASDAQ:CGIX) Stock Technicals at Critical Inflection Point - CML News (NASDAQ:CGIX) news.cmlviz.com - July 22 at 12:20 PM
	Cancer Genetics Inc. Selected by H3 Biomedicine Inc., to Provide Biomarker Discovery and Testing for a Global Drug ... - Yahoo Finance (NASDAQ:CGIX) finance.yahoo.com - July 19 at 4:13 PM
	Cancer Genetics, Inc. (NasdaqCM:CGIX) Fundamental Star Rating Report - CML News (NASDAQ:CGIX) news.cmlviz.com - July 19 at 4:13 PM

Social

Cancer Genetics (NASDAQ:CGIX) Chart for Thursday, September, 29, 2016